ArticleCancer management and research2026
Cytokeratin-Positive Pleomorphic Chest Wall Sarcoma Mimicking MPNST: A Case Report.
Article in Cancer management and research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Undifferentiated pleomorphic sarcoma (UPS) is an uncommon high-grade soft-tissue sarcoma and remains a diagnosis of exclusion because it lacks specific differentiation and pathognomonic markers. Primary chest-wall involvement is rare, and epithelial-marker expression may complicate diagnosis by broadening the differential diagnosis. Case Presentation: A 62-year-old male carpenter and active smoker with diabetes mellitus and ischemic heart disease presented with persistent right-sided chest pain radiating to the back. Examination revealed a firm right anterolateral chest-wall mass fixed to the deep plane. Chest radiography suggested a chest-wall origin, and contrast-enhanced computed tomography demonstrated an extrapleural, lentiform mass displacing the adjacent lung without clear parenchymal invasion. CT-guided core biopsy suggested malignant peripheral nerve sheath tumor. Case Discussion: The patient underwent en bloc resection of the mass, including anterior portions of ribs 3-5 and involved serratus anterior muscle, followed by reconstruction using a polypropylene mesh underlay and orthogonally arranged metallic plates. Histopathology showed a malignant spindle-to-epithelioid pleomorphic neoplasm infiltrating skeletal muscle and encasing trabecular rib bone. Immunohistochemistry demonstrated diffuse vimentin and cytokeratin positivity, mild EMA expression, S100 and myogenin negativity, and focal desmin, actin, and CD68 positivity. Correlating morphology with the available immunoprofile, the resection specimen was most consistent with cytokeratin-positive UPS. The anterior margin was involved, while other margins were free. Conclusion: This case highlights diagnostic pitfalls in cytokeratin-positive pleomorphic chest-wall tumors and the limitations of core biopsy. En bloc resection with rigid reconstruction is feasible, while positive margin status warrants multidisciplinary consideration of adjuvant local therapy and structured surveillance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.